Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Healthequity Inc shares valued at $1,122,483 were purchased by Scott Cutler on Jan 12 ’26. At $89.83 per share, Scott Cutler acquired 12,496 shares.
Also, Michael Henry Fiore purchased 1,744 shares, netting a total of over 166,092 in proceeds.
Before that, James M. Lucania had added 2,470 shares to its account. In a trade valued at $235,233, the Officer bought Healthequity Inc shares for $95.24 each.
As published in a research note from Goldman on January 09, 2026, Healthequity Inc [HQY] has been rated down from a Neutral to a Sell and the price target has been revised to $89. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of November 13, 2025, BMO Capital Markets has initiated its “Market perform” rating for HQY.
Analyzing HQY Stock Performance
On last trading session, Healthequity Inc [NASDAQ: HQY] rose 1.57% to $85.6. The stock’s lowest price that day was $83.01, but it reached a high of $86.54 in the same session. During the last five days, there has been a drop of approximately -12.45%. Over the course of the year, Healthequity Inc shares have dropped approximately -15.93%.
Is Healthequity Inc subject to short interest?
Stocks of Healthequity Inc saw a sharp rise in short interest on 2025-12-31 jumping by 59992.0 shares to 4.41 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 4.35 million shares. A jump of 1.36% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.94 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.94.
Which companies own the most shares of Healthequity Inc (HQY)?
In terms of Healthequity Inc share price expectations, FactSet research, analysts set an average price target of 120 in the next 12 months, up nearly 42.38% from the previous closing price of $84.28. Analysts anticipate Healthequity Inc stock to reach 134 by 2026, with the lowest price target being 89. In spite of this, 11 analysts ranked Healthequity Inc stock as Buy at the end of 2026. On March 25, 2025, Raymond James assigned a price target of “a Strong buy” to the stock and upgraded coverage with a $115.
